SUMMARY
In his classic paper in 1946 on the aspiration of stomach contents during obstetric anaesthesia, Mendelson recommended that gastric contents be alkalinised prior to the induction of general anaesthesia. I Roberts and Shirley,2 and many others 3 - s have suggested that should aspiration occur, the lung damage will be severe if the pH of the aspirate is less than 2.5. Particulate matter, if present, can also cause severe lung damage. Despite these conclusions the optimal acid aspiration prophylaxis is not clear.
The provision of skilled and experienced anaesthesia personnel, and avoidance of general anaesthesia, where possible, are generally regarded as the most reliable safeguards against aspiration pneumonitis in obstetric anaesthesia. However, some method of pharmacologic prophylaxis is generally recommended.
The study was designed to determine what types of prophylaxis are used in Australia and how those practices differed from those regimes used in the United Kingdom, as determined in a similar survey in 1984. 6 METHOD Every public hospital in Australia providing obstetric services was identified in the Australian Hospitals Health Services Year Book (1985) (1986) 
RESULTS
The questionnaire was sent to 567 hospitals and returns were received from 379 (66.8%). Of these, forty were no longer providing obstetric services. As 96 hospitals did not carry out CS, only their responses relating to labouring parturients were relevant. Thus, 243 hospitals fully completed and returned the questionnaire. Hospitals with less than 50 deliveries per annum recorded a 30% response rate, while for those with greater than 50 deliveries per annum the response rate was greater than 50% in all states of Australia. The results are grouped into three sections: (a) labouring parturients (339 hospitals); (b) elective CS patients (243 hospitals); and (c) emergency CS patients (243 hospitals). Results are expressed as a percentage of the number of responding hospitals in each group.
Labouring parturients
Prophylaxis during labour was used by 22.4%. Magnesium trisilicate mixture (8.8%) and Mylanta® (8.2%) were the most popular therapies.
Sodium citrate (5.3%) and/or type-2 histamine receptor antagonists (ranitidine or cimetidine) (0.9%) usage were much less common. Small numbers used other preparations including Gaviscon®, Gastrogel® or sodium bicarbonate preparations. Overall, 15 ml of magnesium trisilicate mixture given every two hours was the most common regime used during labour.
Elective caesarean section
For elective caesarean section no therapy was used by 15.2%. Sodium citrate mixture was the most commonly used agent (36.6%). This was little different from magnesium trisilicate which was used by 33.3%. Type-2 histamine receptor antagonists, usually combined with sodium citrate were used in 11.5% of hospitals. Mylanta® use was reported by 6.1 %. Atropine and metoclopramide were used routinely in 23.8% and 10.2% respectively of responding hospitals.
Overall, 30 ml of sodium citrate mixture within the 30 minutes prior to induction was the most commonly used preparation.
Emergency caesarean section
For emergency caesarean section the results were very similar to the Elective Group. No therapy was used by 11.5%. Sodium citrate was used by 44.4% and magnesium trisilicate by 35.5% and Mylanta® by 8.5%. Type-2 histamine receptor antagonists were used in 3.9% of hospitals, and were usually administered parenterally. Again, atropine (20.0%) and metoclopramide (14.1 %) were popular additional therapies.
Overall, 30 ml of sodium citrate, administered as soon as the decision to operate was made, was the most popular therapy.
Other data from responding hospitals
Of the 243 responding hospitals in which CS was performed, 230 (95%) indicated their annual number of deliveries. 154 of these (66.9%) had less than 500 deliveries per annum. DISCUSSION A full discussion of the indications and recommendations for the pharmacologic prophylaxis of aspiration and its morbidity and mortality is beyond the scope of this paper, and so this discussion only briefly addresses the issues relevant to the data obtained by the survey.
In comparing these data with those of Sweeney and Wright,6 the authors acknowledge that the British survey was conducted three years earlier, so the comparisons may only be considered as approximations of the varying practices.
With regard to prophylaxis during labour, this practice is much less common in Australia (22.4%) than in the V.K. (81.5%). The practice of providing prophylaxis to large numbers of parturients, most of whom will not require anaesthesia of any kind, has been questioned. 8 This low usage of antacids during labour by Australian anaesthetists may represent the opinion that a single dose of antacid (alone or in combination with other agents) provides acceptable protection prior to caesarean section. Documented case reports 9 ,10 indicate that despite frequent doses of magnesium trisilicate mixture, fatal aspiration may occur. It is not known whether these deaths were from food aspiration and thus not preventable with antacid usage, or that the regime of antacid failed to prevent acid aspiration or that the antacid itself contributed to the death. 11 ,12 There is continuing concern that magnesium trisilicate mixture might cause lung damage if aspirated. 12 There appears to be a growing opinion that sodium citrate solution might be a safer agent. With the popularity in Australia of the single dose of antacid prior to CS, the rapid onset and better mixing of sodium citrate solutions becomes most important. This may explain the increasing usage of this agent rather than magnesium trisilicate. In considering potential lung injury from aspirated antacids the mixtures of aluminium and magnesium hydroxides similar to Mylanta® have been strongly criticised in animal research I3 ,14 and human case reports. 15 This mixture does not appear in the Sweeney and Wright survey and thus apparently is not used in Britain for aspiration prophylaxis. The agent has been described 'as useful and as dangerous as cement' in this context. 16 In Australia 11 % of hospitals did not administer prophylaxis prior to emergency caesarean section compared to 0.7% in Britain. This figure suggests that British opinion is that antacid usage is strongly indicated in this situation. The number of deliveries in the Australian hospitals not administering prophylaxis was, in every case, less than 750 per annum, so one might conclude that the practise of 'no prophylaxis' was more common in smaller hospitals. However, three of the sixteen hospitals conducting greater than 2000 deliveries per annum volunteered that some of their anaesthetists did not use prophylactic therapy. It would appear that moderate numbers of Australian anaesthetists do not agree with the British assessment.
The Australian figures (3.9% for emergency CS and 11.5% for elective) demonstrate that the use of type-2 histamine receptor antagonists is much less here than in the V.K. (14.8% and 29.6% respectively).6 Since the late 1970s, type-2 histamine receptor antagonists have been proposed as useful adjuncts in aspiration prophylaxis. 17 ,18 Although it is not certain that this additional prophylaxis provides extra protection, the theoretical argument for their use is impressive and would explain their increasing popularity.
Atropine was commonly used prior to CS (26%). Anticholinergics reduce the tone of the lower oesophageal sphincter which may increase the risk of aspiration in some patients 19 and hence they have little role in acid aspiration prophylaxis. 20 Still, the use of these agents may be necessary prior to induction of general anaesthesia for caesarean section to prevent or to treat suxamethoniuminduced bradycardia. 21 Metoclopramide usage is common in both Australia and the V.K. This agent has a role in increasing gastric motility and in improving the function of the lower oesophageal sphincter. 22 Thus its use has been recommended in those parturients at high risk from aspiration. 23 However, it remains unclear whether metoclopramide (or similar gastrokinetic agents) can overcome the gastric stasis caused by opiates. 23 ,24 In conclusion, this survery has identified that in 1987, the most common pharmacological method of acid aspiration prophylaxis consisted of the administration of sodium citrate as a single dose prior to CS. The use of magnesium trisilicate mixtures was slightly less common while the use of type-2 histamine receptor antagonists was infrequent. Mylanta® is used by a moderate number of hospitals. The use of Mylanta®-type agents has been strongly criticised.
®Mylanta, Gaviscon and Gastrogel are registered trade names.
